SCHEMBL5634720

SCHEMBL5634720

N#C/C(=C\c1c[nH]c2ccc([N+](=O)[O-])cc12)S(=O)(=O)Cc1ccc(Cl)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXFP3 Q9NSD7 1/20 0.52
MAPT P10636 4/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
NPSR1 Q6W5P4 2/20 0.41
POLB P06746 1/20 0.41
GAA P10253 1/20 0.41
HTT P42858 1/20 0.41
LMNA P02545 2/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
HSP90AA1 P07900 1/20 0.41
PKM P14618 1/20 0.41
CCR6 P51684 1/20 0.41
BRAF P15056 1/20 0.41
RRM1 P23921 1/20 0.40
GABRP O00591 4/20 0.40
GABRD O14764 4/20 0.40
GABRA1 P14867 4/20 0.40
GABRB1 P18505 4/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5634721 1.00 RXFP3 (0.52) RXFP3MAPTMEN1KMT2ANPSR1
SCHEMBL4185862 0.88 MAPT (0.47) RXFP3MAPTMEN1KMT2ANPSR1
SCHEMBL4185859 0.88 MAPT (0.47) RXFP3MAPTMEN1KMT2ANPSR1
SCHEMBL4185864 0.88 MAPT (0.47) RXFP3MAPTMEN1KMT2ANPSR1
SCHEMBL5636407 0.87 MAPT (0.55) RXFP3MAPTMEN1KMT2ANPSR1
SCHEMBL5636404 0.87 MAPT (0.55) RXFP3MAPTMEN1KMT2ANPSR1
SCHEMBL4181609 0.84 RXFP3 (0.48) RXFP3MAPTMEN1KMT2ANPSR1
SCHEMBL4181603 0.84 RXFP3 (0.48) RXFP3MAPTMEN1KMT2ANPSR1
SCHEMBL4181607 0.84 RXFP3 (0.48) RXFP3MAPTMEN1KMT2ANPSR1
SCHEMBL4183861 0.82 MAPT (0.44) RXFP3MAPTMEN1KMT2ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070010559-A1 Indole derivatives for use as chemical uncoupler NOVO NORDISK A/S (DK) 2007-01-11 US claimed
US-20070010559-A1 Indole derivatives for use as chemical uncoupler NOVO NORDISK A/S (DK) 2007-01-11 US disclosed
EP-1689710-A1 INDOLE DERIVATIVES FOR USE AS CHEMICAL UNCOUPLER NOVO NORDISK A/S (DK) 2006-08-16 EP disclosed
WO-2005051908-A1 INDOLE DERIVATIVES FOR USE AS CHEMICAL UNCOUPLER NOVO NORDISK A/S (DK) 2005-06-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070010559-A1 Indole derivatives for use as chemical uncoupler GPR119, IDO2, IDO1 RXFP3 1048/4885MAPT 4316/4885MEN1 4192/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.